News
TBDO Sessions Edgardo Ferran
20/06/201916:00CHARLES DARWINTBDO SessionsEdgardo FerranEMBL_EBI visiting scientist/CRG scientific collaboratorAn introduction to Pharma Industry and EBI Industry ProgrammeHost: Montava Guill, EsterAbstract:Why do we need pharma industry? What is the current business model of the big pharma? How drug discovery and development is done in these companies? How many new medicines are approved each year by the regulatory agencies? How the companies communicate their financial and clinical results? What a pharma clinical pipeline looks like? Which strategies do they follow under the risk of a patent cliff? Why pharma companies merge or buy a concurrent company? Which are the scientific subjects that currently interest the big pharma? How...
a href=https://www.crg.eu/en/event/tbdo-sessions-edgardo-ferranTBDO Sessions Edgardo Ferran/a
pspan class=body_120/06/2019/spanspan class=body_216:00/spanspan class=body_3CHARLES DARWIN/spanspan class=body_4TBDO Sessions/spanspan class=body_5Edgardo Ferran/spanspan class=body_6EMBL_EBI visiting scientist/CRG scientific collaborator/spanspan class=body_7An introduction to Pharma Industry and EBI Industry Programme/spanspan class=body_8Host: Montava Guill, Ester/spanspan class=body_9Abstract:/spanWhy do we need pharma industry? What is the current business model of the big pharma? How drug discovery and development is done in these companies? How many new medicines are approved each year by the regulatory agencies? How the companies communicate their financial and clinical results? What a pharma clinical pipeline looks like? Which strategies do they follow under the risk of a patent cliff? Why pharma companies merge or buy a concurrent company? Which are the scientific subjects that currently interest the big pharma? How.../p
Two CRG projects have been awarded ERC Proof of Concept grants
IMPACCT and MycoVAP projects both will receive ERC PoC grants to explore potential clinical applications of their recent results on breast cancer and pneumonia respectively.
Microomics awarded the “Impulso” Prize
The CRG spin off Microomics has been awarded the “Impulso” Prize.
BIST funds five multidisciplinary research projects through the 2017 Ignite awards
CRG will participate in the Phase-Chrom project, led by CRG researcher Catalina Romero and Juan Andrés Torreno at ICFO.
CRG and Eugin sign a collaboration agreement on molecular research applied to assisted reproduction
The project entails collaboration of four working groups that will focus their research on gaining insights into the aging of ovules, their sensitivity to the passage of time, and studying whether...
Microomics, the company that brings together microbes and genomics to improve health, agriculture and industry
A new spin-off born at the CRG, which is devoted to offering metagenomics solutions.
Jordi Hernández awarded the CERCA Pioner Prize 2017
Jordi Hernández, former PhD student at Juan Valcárcel’s laboratory and current CRG Entrepreneur in Residence has been awarded the CERCA Pioneer Prize.
TBDO Sessions Lluís Armengol/Ruth Muñoz/Luis Ruiz/Leandro Vetcher
06/10/201710:00RAMÓN Y CAJALTBDO SessionsLluís Armengol/Ruth Muñoz/Luis Ruiz/Leandro VetcherCSO and CEO of qGenomics/CSO of Leukos Biotech/CEO at Spherium Biomed/Director of Harvard’s Blavatnik Biomedical AcceleratorRound Table discussion in the context of the 4th CRG BioBusiness School.Host: Cironi López, PabloAbstract:These four seasoned and new entrepreneurs in the biotech sector will share their motivations to become entrepreneurs, and experiences in doing so.
TBDO Sessions Lluís Armengol/Ruth Muñoz/Luis Ruiz/Leandro Vetcher
06/10/201710:00RAMÓN Y CAJALTBDO SessionsLluís Armengol/Ruth Muñoz/Luis Ruiz/Leandro VetcherCSO and CEO of qGenomics/CSO of Leukos Biotech/CEO at Spherium Biomed/Director of Harvard’s Blavatnik Biomedical AcceleratorRound Table discussion in the context of the 4th CRG BioBusiness School.Host: Cironi López, PabloAbstract:These four seasoned and new entrepreneurs in the biotech sector will share their motivations to become entrepreneurs, and experiences in doing so.